Of Mice and Men: Using Mutations to Characterize Disease
Of Mice and Men: Using Mutations to Characterize Disease
批准号:
7291859
负责人:
NANCY JENKINS COPELAND
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In previous studies we showed that Mitf encodes a bHLH-Zip transcription factor that is required for melanocyte, osteoclast, and mast cell function. Subsequently, human MITF was cloned and shown to be mutated in a common human pigmentation and hearing disorder, Waardenburg syndrome type 2 (WS2). The cloning of mouse Mitf thus led to the identification of a new important human disease gene. We made germ line mutations in three genes that are closely related to Mitf and whose protein products interact with MITF (Tfe3, Tfeb, and Tfec). We also generated mice that carried different combinations of these four mutations. Our studies showed that Tfeb is required for placental vascularization, while Tfe3 functions in the osteoclasts. Surprisingly, we failed to show any genetic interaction between these four genes. This was unexpected based on the MYC-MAX-MAD paradigm. Both Tfeb and Tfe3 are human disease genes and our studies may help to show how these proteins function in human disease. We also showed that Mitf expression is complex; there are at least 13 different isoforms. Others have shown that MITF functions in a number of signal transduction pathways and undergoes several posttranslational modifications. To further evaluate the requirement for these modifications in vivo, we are using BAC recombineering to create mutations within the mouse Mitf gene that block these modifications and then analyze their effects in animals carrying the BAC and a null allele of Mitf. We are also continuing a sensitized, F1 dominant screen for suppressors and enhancers of MITF. In preliminary studies, we have identified a very interesting intragenic suppressor that we are now characterizing. itch represents one of the few single gene mouse models of human autoimmune disease. Previously, we showed that itch encodes a novel HECT-domain-containing E3 ligase. In recent collaborative studies, we showed that loss of itch function leads to a bias towards Th2 differentiation of T cells in vitro. In recent transplantation studies we also showed that cells residing in the bone marrow of itch mice can confer the disease to lethally irradiated wild type hosts. We are now determining whether a particular class of lymphocytes is sufficient for itch disease and whether itch mice have defects in macrophage function that might predispose them to the Th2 bias. itch is the mouse ortholog of Drosophila Suppressor of deltex, Su(dx), a negative regulator of Notch signaling. In recent studies, we found that mice carrying an activated Notch1 transgene have an autoimmune disease that is similar to that seen in itch mice. We also showed that itch mice carrying the activated Notch1 transgene have an autoimmune disease that is more severe and occurs much earlier than itch or transgenic mice alone. These findings are very interesting because they suggest that both itch and Notch1 may function in the same autoimmune disease pathway. Further characterization of this pathway may have important implications for treating human autoimmune diseases. Finally, we are also determining the functional overlap between ITCH and the closely related E3 ligases WWP1 and WWP2 by examining the phenotype of mice carrying combinations of mutations in these three genes. Mice homozygous for the semidominant Crc mutation die during development from severe neural tube defects similar to those observed in Lp mice. Crc and Lp genetically interact at the level of neural tube closure, suggesting that they function in the same signaling pathway. Lp encodes a homolog of the Drosophila vang/stbm gene (Vangl2), a potential member of the Wnt signaling pathway, while Crc encodes Scrb1, a PDZ domain-containing gene that is the ortholog of Drosophila scribble. In flies, scribble is required for the correct localization of apical domain proteins and for the generation of epithelial polarity.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Genetic Study of Pigment Granule Transport in the Mouse
-
批准号:6559259
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:NANCY JENKINS COPELAND
-
依托单位:
MOLECULAR GENETICS OF BHLH-ZIP TRANSCRIPTION FACTORS
-
批准号:6423819
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:NANCY JENKINS COPELAND
-
依托单位:
Molecular Genetics--Mitf-Tfe Family of bHLH-Zip
-
批准号:6559260
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:NANCY JENKINS COPELAND
-
依托单位:
UNDERSTANDING NEURAL DEVELOPMENT THROUGH MUTATIONS
-
批准号:6423820
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:NANCY JENKINS COPELAND
-
依托单位:
Understanding Neural Development--Use of Mouse Mutations
-
批准号:6559261
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:NANCY JENKINS COPELAND
-
依托单位:
Of Mice and Men: Using Mutations to Characterize Disease
-
批准号:6952171
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:NANCY JENKINS COPELAND
-
依托单位:
A Genetic Approach to the Study of Vesicle Transport in
-
批准号:7053838
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:NANCY JENKINS COPELAND
-
依托单位:
A Genetic Approach to the Study of Vesicle Transport in
-
批准号:7291780
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:NANCY JENKINS COPELAND
-
依托单位:
GENETIC APPROACH STUDY OF PIGMENT GRANULE TRANSPORT
-
批准号:6423812
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:NANCY JENKINS COPELAND
-
依托单位:
A Genetic Approach to the Study of Vesicle Transport
-
批准号:6951681
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:NANCY JENKINS COPELAND
-
依托单位:
国内基金
海外基金
登录
查看更多内容
MEN1 失活通过 PCP4/NR2F6/MLL1轴调控 MGMT 影响胰腺神经内分泌瘤替莫唑胺化疗耐药的机制研究
-
批准号:25TS1403500
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:吉顺荣
-
依托单位:
MEN1失活通过PCP4/NR2F6/MLL1轴调控MGMT影响胰腺神经内分泌瘤替莫唑胺化疗耐药的机制研究
-
批准号:25TS1403500
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:吉顺荣
-
依托单位:
MEN1失活通过ZDHHC9介导的MGMT棕榈酰化修饰调控胰腺神经内分泌瘤替莫唑胺化疗耐药的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:胥俊峰
-
依托单位:
肺腺癌中MEN1通过调控ZNF146影响肿瘤免疫微环境的功能和机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘银
-
依托单位:
基于PhO--Men+配位的超分子抑制剂强化碳酸盐型萤石矿浮选分离机制研究
-
批准号:JCZRQN202500079
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
MEN1-HMGCR胆固醇代谢途径调控胰腺神经内分泌瘤进展的作用和机制研究
-
批准号:82303943
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:叶增
-
依托单位:
MEN1通过代谢重编程介导ATRX功能改变促进胰腺神经内分泌肿瘤进展的机制研究
-
批准号:82372696
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:王小兵
-
依托单位:
MEN1调控ZNRF3介导糖代谢异常促进胰腺神经内分泌瘤发生发展的机制研究
-
批准号:82302943
-
项目类别:青年科学基金项目
-
资助金额:20万元
-
批准年份:2023
-
负责人:马亚锐
-
依托单位:
臭椿酮靶向KMT2A-MEN1表观遗传抑制丝氨酸合成抗骨肉瘤肺转移的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:张剑军
-
依托单位:
Men1突变(G503D)以及Men1缺失导致中间神经元功能紊乱在抑郁发生发展中的作用机制研究
-
批准号:82071520
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:冷历歌
-
依托单位: